Kansai Paint Valuation

Is KAP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KAP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KAP (€12.8) is trading below our estimate of fair value (€16.42)

Significantly Below Fair Value: KAP is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for KAP?

Key metric: As KAP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for KAP. This is calculated by dividing KAP's market cap by their current earnings.
What is KAP's PE Ratio?
PE Ratio10.8x
EarningsJP¥36.34b
Market CapJP¥393.29b

Price to Earnings Ratio vs Peers

How does KAP's PE Ratio compare to its peers?

The above table shows the PE ratio for KAP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average28.4x
WCH Wacker Chemie
28.8x37.0%€3.6b
ACT AlzChem Group
12.1x12.6%€608.5m
EVK Evonik Industries
35.4x33.1%€8.1b
SY1 Symrise
37.1x13.2%€14.6b
KAP Kansai Paint
10.8x-1.0%€393.3b

Price-To-Earnings vs Peers: KAP is good value based on its Price-To-Earnings Ratio (10.8x) compared to the peer average (28.4x).


Price to Earnings Ratio vs Industry

How does KAP's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
KAP 10.8xIndustry Avg. 16.8xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: KAP is good value based on its Price-To-Earnings Ratio (10.8x) compared to the European Chemicals industry average (16.8x).


Price to Earnings Ratio vs Fair Ratio

What is KAP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KAP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio10.8x
Fair PE Ratio12.1x

Price-To-Earnings vs Fair Ratio: KAP is good value based on its Price-To-Earnings Ratio (10.8x) compared to the estimated Fair Price-To-Earnings Ratio (12.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KAP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€12.80
€16.69
+30.4%
10.5%€20.13€14.03n/a9
Nov ’25€14.50
€17.77
+22.6%
8.2%€20.40€14.83n/a9
Oct ’25€15.70
€18.53
+18.0%
8.5%€21.14€15.37n/a9
Sep ’25€15.90
€17.42
+9.5%
8.8%€20.27€14.74n/a9
Aug ’25€14.90
€16.92
+13.5%
8.1%€19.17€14.38n/a9
Jul ’25€14.50
€15.88
+9.5%
11.3%€18.05€11.65n/a8
Jun ’25€15.00
€15.08
+0.5%
14.8%€18.25€11.77n/a8
May ’25€11.90
€15.25
+28.2%
13.5%€18.10€12.07n/a8
Apr ’25€12.80
€16.42
+28.2%
10.6%€18.50€13.57n/a6
Mar ’25€13.10
€16.61
+26.8%
7.8%€18.38€14.64n/a6
Feb ’25€15.10
€17.21
+14.0%
6.9%€18.80€15.67n/a6
Jan ’25€15.00
€17.21
+14.8%
6.9%€18.80€15.67n/a6
Dec ’24€13.70
€17.20
+25.6%
7.1%€18.56€15.47n/a6
Nov ’24€13.50
€16.91
+25.3%
11.4%€18.96€13.59€14.506
Oct ’24€13.20
€16.91
+28.1%
11.4%€18.96€13.59€15.706
Sep ’24€14.80
€16.39
+10.7%
9.8%€18.53€13.51€15.907
Aug ’24€14.60
€15.79
+8.1%
8.3%€17.32€13.79€14.907
Jul ’24€13.10
€15.71
+19.9%
7.6%€16.69€13.49€14.507
Jun ’24€13.80
€15.49
+12.3%
10.3%€16.67€12.07€15.007
May ’24€12.50
€15.09
+20.7%
9.4%€16.65€12.06€11.907
Apr ’24€12.00
€15.41
+28.4%
11.0%€17.36€11.67€12.807
Mar ’24€11.80
€15.67
+32.8%
11.9%€17.66€11.45€13.107
Feb ’24€12.30
€15.67
+27.4%
11.9%€17.66€11.45€15.107
Jan ’24€11.20
€15.39
+37.4%
10.8%€17.30€12.25€15.007
Dec ’23€12.90
€15.80
+22.5%
13.4%€18.81€12.33€13.706
Nov ’23€12.90
€17.13
+32.8%
15.0%€20.39€13.18€13.506

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies